ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,247.79
-0.41%
Dow Jones
39,112.16
-0.76%
Gold vs US Dollar
2,317.97
-0.12%
Brent Oil
84.645
0.55%
Bitcoin
61,644.23
-0.26%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Spyre Therapeutics Inc (SYRE) Share Price

SYRE Spyre Therapeutics Inc

23.51
-0.72 (-2.97%)
26 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Spyre Therapeutics Inc NASDAQ:SYRE NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.72 -2.97 23.51 22.80 25.00 24.77 22.63 24.11 930,994 23:29:22   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 886k -338.79M -6.6714 -3.43 1.16B
 Type  Size  Price  Time  Units 
 23 117,100 23.09 20:58:14 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SYRE News
18/06/202412:30PRNUSSpyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-α4β7 Antibody, for the Treatment of Inflammatory Bowel Disease
03/06/202422:23PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
30/05/202421:33EDGAR2Form 8-K - Current report
29/05/202413:30PRNUSSpyre Therapeutics to Participate in the Jefferies Global Healthcare Conference
16/05/202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
16/05/202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
16/05/202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for SYRE

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Spyre Therapeutics Inc Articles